Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000481008 | SCV000572034 | likely pathogenic | not provided | 2016-10-27 | criteria provided, single submitter | clinical testing | The I21T variant in the CDC42 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The I21T variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The I21T variant is a non-conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. The I21T variant is a strong candidate for a pathogenic variant which may be related to the clinical features in this individual. However, the possibility it may be a rare benign variant cannot be excluded. |
OMIM | RCV000601771 | SCV000734810 | pathogenic | Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome | 2018-04-06 | no assertion criteria provided | literature only | |
University of Washington Center for Mendelian Genomics, |
RCV001291419 | SCV001479920 | likely pathogenic | Abnormal facial shape; Abnormality of blood and blood-forming tissues; Abnormality of the immune system; Postnatal growth retardation; Neurodevelopmental abnormality | no assertion criteria provided | research |